摘要
中华医学会肝病学分会组织相关专家对《非酒精性脂肪性肝病防治指南(2018更新版)》进行了修订,更名为《代谢相关(非酒精性)脂肪性肝病防治指南(2024年版)》,对代谢相关脂肪性肝病的筛查和监测、诊断和评估、治疗和随访等临床问题提出了指导性建议。
The Chinese Society of Hepatology of the Chinese Medical Association invited relevant experts to revise and update the Guideline of Prevention and Treatment of Nonalcoholic Fatty Liver Disease(2018Version)and renamed it as(Version 2024)Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated(non-alcoholic)Fatty Liver Disease.Herein,the guiding recommendations on clinical issues such as screening and monitoring,diagnosis and evaluation,treatment and follow-up of metabolic dysfunction-associated fatty liver disease are put forward.
作者
中华医学会肝病学分会
范建高
南月敏
魏来
徐小元
贾继东
庄辉
施军平
李小英
孙超
李婕
黄炜燊
段钟平
Chinese Society of Hepatology,Chinese Medical Association;Fan Jiangao;Nan Yuemin;Wei Lai(不详;Department of Gastroenterology,Xinhua Hospital Afiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200092,China;Department of Traditional and Western Medical Hepatology,Hebei Medical University Third Hospital,Shijiazhuang 050051,China;Hepatopancreatobiliary Center,Beijing Tsinghua Changgung Hospital,School of Clinical Medicine,Tsinghua University,Beijing 102218,China)
出处
《中华肝脏病杂志》
CAS
CSCD
北大核心
2024年第5期418-434,共17页
Chinese Journal of Hepatology
关键词
非酒精性脂肪性肝病
脂肪性肝病
代谢相关脂肪性肝病
诊断
治疗
预后
指南
Non-alcoholic fatty liver disease
Fatty liver disease
Metabolic associated fatty liver disease
Diagnosis
Therapeutic
Prognosis
Guideline
